Navigation Links
Finnpipette Digital Single Channel, 0.5-10ul, micro

ProductsFinnpipette Digital Single Channel, 0.5-10ul, micro
Company ThermoFisher Scientific
Item Finnpipette Digital Single Channel, 0.5-10ul, micro
Features 
Description The Finnpipette Digital offers improved ergonomics for today's exacting laboratory routines. The rounded handle, modified grippy finger rest and the large display windows enhance operator comfort and efficiency. Finnpipette Digitals also feature soft-touch tip ejection with power-boosted gearing mechanism (pat. pend.) and super blow-out for 0.2 - 50ul micro volume pipetting. For absolute sterility, all Finpipette Digitals are completely autoclavable.
Info ThermoFisher Scientific
Customer Service: (800) 637-3717
Web site: http://www.thermofisher.com/global/en/home.asp

Related medicine products :

1. Finnpipette BioMate Pipette Aid
2. Finnpipette Digital Single Channel, 200-1000ul
3. Finnpipette Digital Single Channel, 100-1000ul
4. Finnpipette Focus Single Channel, 100-1000ul
5. Finnpipette Techpette Single Channel, 100-1000ul
6. Finnpipette Techpette Single Channel, 20-200ul
7. Finnpipette Digital Single Channel, 20-200ul
8. Finnpipette Digital Single Channel, 2-20ul
9. Finnpipette Techpette Single Channel, 0.5-10ul
10. Finnpipette Focus Single Channel, 1-10ul
11. Finnpipette Focus Single Channel, 1-10ul, micro
Right Dr. White Carina Hook
SHERIDAN LASER-TRACH Endotracheal Tubes
SHERIDAN LAR-A-JECT® Reinforced Laryngectomy Tubes
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes
Medicine Products:
(Date:12/2/2009)...ndall Hunt authors earned the 2009 Gifted Child Qu...onal Association for Gifted Children’s annua... Dubuque, IA (PRWEB) Decemb...d the 2009 Gifted Child Quarterly Paper of the Yea...ted Children’s annual conference in St. Loui...
(Date:12/2/2009)...re/ -- In response to rising suicide and divorce r...rofit ministry dedicated to supporting marriages a...® marriage conference at a significant disco...13 at the Grand Hyatt Atlanta in Buckhead (3300 Pe...iage getaway aimed at strengthening healthy marria...
(Date:12/2/2009)...paign Features Small Business Owners Detailing How... Jobs ,, WASHINGTON, Dec. 2 /PRNewswire-USNews...led for Thursday, Keeping Small Business Healthy, ...unced a new $1 million 4 state TV ad campaign targ...h care legislation on small business owners and ho...
(Date:12/2/2009)...RNewswire-USNewswire/ -- At a recently concluded f...delegates came together to outline the future of m...he necessary thrust. Organized by the Medical Tour...tion.com , the high-powered congregation of senior...nities and requests for assistance in medical tour...
(Date:12/2/2009)..., Dec. 2 Lockton Benefit Group i...cal view on proposed health reform legislation wor...newscom.com/cgi-bin/prnh/20090415/CG99351LOGO ) ,... the legislation, according to Ed Fensholt and Mar...Compliance Services Division and Lockton,s Healt...
Breaking Medicine News(10 mins):Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2Health News:FamilyLife Supports Military Marriages in Atlanta 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 3Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 4Health News:Ministerial Roundtable Discusses Future of Medical Tourism 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 3Health News:Lockton Outlines Implications of Proposed Health Reform Plans 2
...aid that older hospital patients with delirium run...e condition. Researchers suggested there's a need ...nt can be made and to investigate interventions th...onal delirium - described as possible hallucinatio...
... may be only a dash and sprinkel away: Researchers...d that herbs, in addition to making food tastier, ...rovide potential anticancer benefits when suppleme...dings appear in the Journal of Agricultural and Fo...
...a recent study a device was found using new techno... of screening people for potential stroke involves...arotid arteries that serve the brain.// Resear...e, this was used to take two different images in a...
...hat protects children against measles, mumps and r... growing list of scarce drugs, with shortfalls cau... pharmaceutical companies choosing to stop making ...neumococcal vaccine used to prevent bacterial meni...
...s are confirming in laboratory studies that one of...ted from beehives--may inhibit the development of ...inas, Brazil, found that propolis// considerably r...promote the binding of cariogenic bacteria to teet...
...now say that a region in the brain responsible for...pathise for others and help the needy. Neuroscient... brain regions involved in learning by imitation./...inguish the self from others.The research, done by...
Other Medicine News:Health News:Herbs: rich soure of antioxidants 2Health News:The brain wave 2
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNewsw...e" or the "Company") (NYSE: SCR ), a leading pha...t, manufacturing, and marketing of branded,generic...eported that its,subsidiary Jiangsu Yanshen Biolog...) has suspended production of all its products in ...
(Date:12/2/2009)..., , EAST HANOVER, N.J., Dec. 2 /PRN..., including a late-breaking presentation on Tasign...hronic myeloid leukemia, demonstrate the strength ... the care of patients. ,, The new data, at the...Meeting and Exposition, highlight the company,s cu...
(Date:12/1/2009)..., , TEMECULA, Calif., Dec. 1 /PRNewswire-Fi... Bulletin Board: PSTX) announced today that it has...of Chief Financial Officer, Treasurer and Corporat...cting CFO since 2008. Prior to joining Patient Sa...nt Finance, Chief Financial Officer, Treasurer and...
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Humans Can Develop Bat Like Echolocation 51093 1Humans Can Develop Bat Like Echolocation 51093 2Communicating science to decision makers 51089 1Omega 3s Benefit Heart Attack Survivors Healthy Adults Mothers and Infants 51086 1Omega 3s Benefit Heart Attack Survivors Healthy Adults Mothers and Infants 51086 2